NTRK2 (Q16620) variants and mutations
NTRK2 (also known as Q16620) is a human protein-coding gene encoding a BDNF/NT-3 growth factors receptor protein. BDNF and neurotrophin-4 signaling through this pathway promotes neuronal survival, synaptic plasticity, and circuit maturation. Rare germline variants can cause neurodevelopmental or metabolic phenotypes, while oncogenic NTRK2 fusions can drive diverse cancers. This analysis covers 2,449 NTRK2 variants and mutations. Of these, 36% have computational variant effect predictions. Disease context includes obesity, hyperphagia, and developmental delay, non-small cell lung carcinoma, and neoplasm. Example NTRK2 variants include S2*, S2A, and S2L.
Variant analysis overview
- Gene: NTRK2
- Protein: Q16620
- UniProt accession: Q16620
- Organism: Homo sapiens
- Variants analyzed: 2449
- Variant scope: all variants
- Completed: 2026-08-18
Variant and mutation evidence
- Variant composition: 2,283 unspecified-consequence records; 75 synonymous variants; 74 missense variants; 1 in-frame deletions; 6 frameshift variants; 2 stop-gained variants; 1 protein altering variant; 6 splice-region variants; 1 substitution
- Prediction scores: 880 variants have prediction scores (36% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: obesity, hyperphagia, and developmental delay, non-small cell lung carcinoma, neoplasm, cancer, genetic developmental and epileptic encephalopathy, neurodegenerative disease, keratitis, undetermined early-onset epileptic encephalopathy, infantile spasms, pancreatic ductal adenocarcinoma, hereditary disease, pilocytic astrocytoma.
Protein structure and variant hotspots
- Protein features: 1 transmembrane segments; 5 domains; 2 binding sites; 16 post-translational modification sites.
- Structural context: 1,669 variants have structural context.
- PTM context: 48 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable NTRK2 variants
Examples include S2*, S2A, S2L, S2W, S2S, S3C, S3P, S3T. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- S2* (p.Ser2Ter), TOPMed rs1181805012, gnomAD rs1181805012, Uncertain significance
- S2A (p.Ser2Ala), Ensembl rs2131265317
- S2L (p.Ser2Leu), TOPMed rs1181805012, gnomAD rs1181805012, REVEL 0.05, CADD 18.00, Uncertain significance, not provided
- S2W (p.Ser2Trp), rs1181805012, ClinGen CA374004526, ClinVar RCV002796035, TOPMed rs1181805012, REVEL 0.26, CADD 23.30, Uncertain significance, not provided
- S2S (p.Ser2Ser), gnomAD 9-84670754-G-C, CADD 14.00
- S3C (p.Ser3Cys), Ensembl rs2131265441
- S3P (p.Ser3Pro), gnomAD 9-84670755-T-C, REVEL 0.12, CADD 21.60
- S3T (p.Ser3Thr), gnomAD 9-84670755-T-A, REVEL 0.07, CADD 19.00
- W4C (p.Trp4Cys), gnomAD 9-84670760-G-T, REVEL 0.49, CADD 32.00
- I5R (p.Ile5Arg), Ensembl rs2131265507
- I5V (p.Ile5Val), TOPMed rs981883098, REVEL 0.06, CADD 22.20
- R6W (p.Arg6Trp), gnomAD 9-84670764-A-T, REVEL 0.35, CADD 32.00
- R6R (p.Arg6Arg), rs2131265532, gnomAD 9-84670766-G-A, CADD 14.70
- W7* (p.Trp7Ter), Ensembl rs76318698
- W7G (p.Trp7Gly), Ensembl rs1587817911
- H8R (p.His8Arg), gnomAD 9-84670771-A-G, REVEL 0.20, CADD 20.80
- G9E (p.Gly9Glu), TOPMed rs1421322179, gnomAD rs1421322179, REVEL 0.49, CADD 25.40
- G9R (p.Gly9Arg), rs1373336521, ClinGen CA374004573, ClinVar RCV001837231, ClinVar RCV003382650, REVEL 0.46, CADD 26.00, Conflicting interpretations, Developmental and epileptic encephalopathy, 58; Obesity, hyperphagia, and develo
- G9V (p.Gly9Val), cosmic curated COSV99457, TOPMed rs1421322179, gnomAD rs1421322179, REVEL 0.50, CADD 25.50
- G9A (p.Gly9Ala), gnomAD 9-84670774-G-C, REVEL 0.41, CADD 23.50
- G9G (p.Gly9Gly), rs767314128, gnomAD 9-84670775-A-C, CADD 14.10
- P10A (p.Pro10Ala), rs1359560976, ClinGen CA374004580, ClinVar RCV003863022, REVEL 0.28, CADD 20.40, Uncertain significance, not provided
- P10H (p.Pro10His), rs1432834509, ClinGen CA374004582, NCI-TCGA Cosmic COSV5286, NCI-TCGA Cosmic COSV5288, AlphaMissense 0.13, MetaLR 0.41, Uncertain significance, not provided
- P10L (p.Pro10Leu), cosmic curated COSV52862, REVEL 0.37, CADD 23.90
- P10S (p.Pro10Ser), TOPMed rs1359560976, gnomAD rs1359560976, REVEL 0.34, CADD 23.20, Uncertain significance, not provided
- P10T (p.Pro10Thr), NCI-TCGA Cosmic COSV5286, cosmic curated COSV52864, Variant assessed as somatic; moderate impact.
- P10P (p.Pro10Pro), rs1245507774, gnomAD 9-84670778-C-T, CADD 13.60
- A11P (p.Ala11Pro), cosmic curated COSV52888
- A11S (p.Ala11Ser), rs78936193, ClinGen CA5105392, ClinVar RCV000735072, ClinVar RCV001816809, REVEL 0.07, CADD 21.90, Conflicting interpretations, not provided; not specified
- A11T (p.Ala11Thr), cosmic curated COSV52888, 1000Genomes rs78936193, ESP rs78936193, ExAC rs78936193, REVEL 0.06, CADD 22.40, Benign
- A11A (p.Ala11Ala), rs2058650768, gnomAD 9-84670781-C-T, CADD 14.90
- M12I (p.Met12Ile), ExAC rs777390281, gnomAD rs777390281, REVEL 0.15, CADD 23.10
- M12V (p.Met12Val), gnomAD 9-84670782-A-G, REVEL 0.14, CADD 20.60
- A13T (p.Ala13Thr), Ensembl rs2131265919
- A13V (p.Ala13Val), cosmic curated COSV52853, REVEL 0.04, CADD 21.80
- A13A (p.Ala13Ala), rs202111140, gnomAD 9-84670787-G-A, CADD 14.80
- R14Q (p.Arg14Gln), NCI-TCGA Cosmic COSV5287, cosmic curated COSV52876, REVEL 0.09, CADD 22.80, Variant assessed as somatic; moderate impact.
- R14W (p.Arg14Trp), rs2058651148, ClinGen CA374004604, NCI-TCGA Cosmic COSV5285, cosmic curated COSV52855, REVEL 0.39, CADD 24.60, Uncertain significance, not provided
- L15H (p.Leu15His), rs756957794, ClinGen CA5105396, ClinVar RCV001920406, ExAC rs756957794, AlphaMissense 0.19, MetaLR 0.41, Uncertain significance, not provided
- L15P (p.Leu15Pro), ExAC rs756957794, gnomAD rs756957794, REVEL 0.53, AlphaMissense 0.19, Uncertain significance
- L15I (p.Leu15Ile), gnomAD 9-84670791-C-A, REVEL 0.03, CADD 16.30
- W16S (p.Trp16Ser), gnomAD 9-84670795-G-C, REVEL 0.36, CADD 23.20
- G17R (p.Gly17Arg), Ensembl rs1465892427
- F18L (p.Phe18Leu), cosmic curated COSV52873
- F18V (p.Phe18Val), TOPMed rs1172673440, gnomAD rs1172673440, REVEL 0.32, CADD 22.90
- C19F (p.Cys19Phe), ExAC rs200698390, gnomAD rs200698390, REVEL 0.38, CADD 22.90, Uncertain significance
- C19Y (p.Cys19Tyr), rs200698390, ClinGen CA374004639, NCI-TCGA Cosmic COSV9945, cosmic curated COSV99453, REVEL 0.45, CADD 23.20, Uncertain significance, NTRK2-related disorder; Developmental and epileptic encephalopathy, 58
- W20* (p.Trp20Ter), TOPMed rs2058652129, gnomAD rs2058652129
- W20C (p.Trp20Cys), TOPMed rs2058652129, gnomAD rs2058652129, REVEL 0.21, CADD 23.90
- L21L (p.Leu21Leu), rs2131266309, gnomAD 9-84670809-C-T, CADD 12.80
- V22A (p.Val22Ala), rs772667595, ClinGen CA5105399, cosmic curated COSV52878, ClinVar RCV002032873, REVEL 0.03, CADD 11.20, Uncertain significance, not provided
- V22G (p.Val22Gly), ExAC rs772667595, gnomAD rs772667595, Uncertain significance
- V22I (p.Val22Ile), gnomAD 9-84670812-G-A, REVEL 0.04, CADD 17.20
- V23G (p.Val23Gly), Ensembl rs1587818326
- V23M (p.Val23Met), rs78480824, ClinGen CA5105400, ClinVar RCV002752104, ClinVar RCV003777703, REVEL 0.08, CADD 9.98, Uncertain significance, not provided; Inborn genetic diseases
- V23V (p.Val23Val), rs1454418060, gnomAD 9-84670817-G-A, CADD 10.80
- G24S (p.Gly24Ser), ExAC rs747519919, gnomAD rs747519919, REVEL 0.22, CADD 24.40
- G24A (p.Gly24Ala), gnomAD 9-84670819-G-C, REVEL 0.07, CADD 19.70
- G24G (p.Gly24Gly), rs1353309636, gnomAD 9-84670820-C-T, CADD 13.30
- F25L (p.Phe25Leu), Ensembl rs2131266562, REVEL 0.04, CADD 16.90
- W26R (p.Trp26Arg), 1000Genomes rs199900277, ExAC rs199900277, gnomAD rs199900277, REVEL 0.59, CADD 26.20
- R27G (p.Arg27Gly), gnomAD rs1181332313, REVEL 0.44, CADD 24.50
- R27M (p.Arg27Met), NCI-TCGA Cosmic COSV9945, cosmic curated COSV99453, Variant assessed as somatic; moderate impact.
- R27T (p.Arg27Thr), gnomAD 9-84670828-G-C, REVEL 0.48, CADD 22.70
- R27K (p.Arg27Lys), gnomAD 9-84670828-G-A, REVEL 0.33, CADD 22.30
- A28G (p.Ala28Gly), Ensembl rs1587818463
- A28T (p.Ala28Thr), Ensembl rs2131266633
- A28D (p.Ala28Asp), gnomAD 9-84670831-C-A, REVEL 0.26, CADD 16.90
- A28A (p.Ala28Ala), rs776677354, gnomAD 9-84670832-C-G, CADD 8.64
- A29T (p.Ala29Thr), gnomAD rs1440777069, REVEL 0.26, CADD 22.30
- A29V (p.Ala29Val), rs2058654001, ClinGen CA374004706, ClinVar RCV002702648, TOPMed rs2058654001, AlphaMissense 0.10, MetaLR 0.29, Uncertain significance, Inborn genetic diseases
- A29A (p.Ala29Ala), gnomAD 9-84670835-T-G, CADD 7.72
- F30S (p.Phe30Ser), TOPMed rs1186058354
- F30Y (p.Phe30Tyr), gnomAD 9-84670837-T-A, REVEL 0.11, CADD 19.70
- F30F (p.Phe30Phe), rs2058654446, gnomAD 9-84670838-C-T, CADD 4.32
- A31P (p.Ala31Pro), rs370304899, ClinGen CA374004716, ClinVar RCV002919257, ClinVar RCV003126260, REVEL 0.75, CADD 23.20, Conflicting interpretations, not provided; Autism spectrum disorder
- A31S (p.Ala31Ser), ESP rs370304899, ExAC rs370304899, TOPMed rs370304899, gnomAD rs370304899, REVEL 0.60, CADD 22.50, Uncertain significance
- A31T (p.Ala31Thr), rs370304899, ClinGen CA5105405, cosmic curated COSV52858, ClinVar RCV001921425, REVEL 0.72, CADD 20.90, Uncertain significance, not provided
- C32Y (p.Cys32Tyr), Ensembl rs2131266948
- P33A (p.Pro33Ala), NCI-TCGA Cosmic COSV5288, cosmic curated COSV52886, REVEL 0.83, CADD 24.50, Variant assessed as somatic; moderate impact.
- T34A (p.Thr34Ala), rs143073407, ClinGen CA5105406, ClinVar RCV001915633, ClinVar RCV004746500, REVEL 0.20, CADD 8.64, Uncertain significance, not provided
- T34K (p.Thr34Lys), cosmic curated COSV52867
- T34M (p.Thr34Met), cosmic curated COSV52853, ExAC rs759206123, TOPMed rs759206123, gnomAD rs759206123, REVEL 0.28, CADD 11.50, Uncertain significance
- T34R (p.Thr34Arg), rs759206123, ClinGen CA374004736, ClinVar RCV003020666, ClinVar RCV004068529, REVEL 0.45, CADD 8.34, Uncertain significance, Inborn genetic diseases; not provided
- T34T (p.Thr34Thr), rs2131267070, gnomAD 9-84670850-G-A, CADD 11.70
- S35F (p.Ser35Phe), NCI-TCGA Cosmic COSV5288, cosmic curated COSV52883, Ensembl rs2131267135, Variant assessed as somatic; moderate impact.
- S35P (p.Ser35Pro), rs2131267111, ClinGen CA374004739, ClinVar RCV001794716, Ensembl rs2131267111, AlphaMissense 0.07, MetaLR 0.74, Uncertain significance, not provided
- C36* (p.Cys36Ter), rs2058655147, ClinGen CA374004750, ClinVar RCV001266336, Ensembl rs2058655147, Uncertain significance
- C36Y (p.Cys36Tyr), Ensembl rs2131267211
- C38F (p.Cys38Phe), ExAC rs767325817, gnomAD rs767325817
- C38S (p.Cys38Ser), Ensembl rs2131267277
- C38Y (p.Cys38Tyr), ExAC rs767325817, gnomAD rs767325817
- S39G (p.Ser39Gly), ESP rs147067960, Uncertain significance
- S39R (p.Ser39Arg), rs147067960, ClinGen CA195738460, ClinVar RCV002843445, ESP rs147067960, REVEL 0.73, CADD 25.40, Uncertain significance, not provided
- A40S (p.Ala40Ser), TOPMed rs2058655519
- A40T (p.Ala40Thr), TOPMed rs2058655519
- A40V (p.Ala40Val), cosmic curated COSV10587
- A40A (p.Ala40Ala), gnomAD 9-84670868-C-A, CADD 10.80
- S41C (p.Ser41Cys), cosmic curated COSV99460
- S41F (p.Ser41Phe), ExAC rs760689213, TOPMed rs760689213, gnomAD rs760689213, REVEL 0.47, CADD 22.40
- S41T (p.Ser41Thr), gnomAD rs1454412423, REVEL 0.31, CADD 16.40
- R42Q (p.Arg42Gln), cosmic curated COSV99451, Ensembl rs76060730, REVEL 0.71, CADD 26.30
- R42W (p.Arg42Trp), TOPMed rs1420992400, gnomAD rs1420992400, REVEL 0.78, CADD 25.20
- R42G (p.Arg42Gly), gnomAD 9-84670872-C-G, REVEL 0.75, CADD 22.70
- R42R (p.Arg42Arg), rs1420992400, gnomAD 9-84670872-C-A, CADD 12.30
- I43I (p.Ile43Ile), gnomAD 9-84670877-C-T, CADD 13.70
- W44* (p.Trp44Ter), Ensembl rs2131267680
- W44C (p.Trp44Cys), Ensembl rs2131267680, REVEL 0.82, CADD 28.50
- C45* (p.Cys45Ter), cosmic curated COSV52872
- C45F (p.Cys45Phe), cosmic curated COSV52853
- C45Y (p.Cys45Tyr), NCI-TCGA Cosmic COSV5285, NCI-TCGA Cosmic COSV5286, cosmic curated COSV52864, REVEL 0.92, CADD 29.60, Variant assessed as somatic; moderate impact.
- C45C (p.Cys45Cys), rs1413475988, gnomAD 9-84670883-C-T, CADD 14.20
- S46N (p.Ser46Asn), gnomAD rs1171041569
- S46R (p.Ser46Arg), rs1211901247, ClinGen CA374004813, ClinVar RCV003408670, TOPMed rs1211901247, REVEL 0.55, CADD 20.30, Uncertain significance, NTRK2-related disorder
- S46S (p.Ser46Ser), rs376605075, gnomAD 9-84670886-C-T, CADD 11.80
- D47E (p.Asp47Glu), Ensembl rs2131267899, REVEL 0.24, CADD 15.80
- D47N (p.Asp47Asn), NCI-TCGA Cosmic COSV9945, cosmic curated COSV99454, Ensembl rs78200643, Variant assessed as somatic; moderate impact.
- D47V (p.Asp47Val), Ensembl rs2131267869
- D47Y (p.Asp47Tyr), Ensembl rs78200643, REVEL 0.73, CADD 26.30
- P48L (p.Pro48Leu), ExAC rs756974214, gnomAD rs756974214, REVEL 0.77, CADD 26.60
- P48T (p.Pro48Thr), Ensembl rs2131267937
- P48P (p.Pro48Pro), rs1330378026, gnomAD 9-84670892-T-C, CADD 15.40
- S49F (p.Ser49Phe), gnomAD rs1371476425, REVEL 0.39, CADD 20.60
- S49T (p.Ser49Thr), gnomAD 9-84670893-T-A, REVEL 0.23, CADD 19.80
- P50A (p.Pro50Ala), TOPMed rs2058658126
- P50S (p.Pro50Ser), rs2058658126, ClinGen CA374004840, ClinVar RCV002891118, cosmic curated COSV52866, REVEL 0.59, CADD 22.60, Uncertain significance, not provided
- P50del (p.Pro50del), rs1157137277, gnomAD 9-84670893-TCTC-T, CADD 19.30
- P50P (p.Pro50Pro), rs2058658255, gnomAD 9-84670898-T-C, CADD 5.19
- G51D (p.Gly51Asp), Ensembl rs938587244, REVEL 0.92, CADD 23.50, Uncertain significance, Inborn genetic diseases
- G51S (p.Gly51Ser), gnomAD 9-84670899-G-A, REVEL 0.77, CADD 23.50
- G51V (p.Gly51Val), gnomAD 9-84670900-G-T, REVEL 0.94, CADD 28.70
- I52F (p.Ile52Phe), cosmic curated COSV52854, Uncertain significance, not provided
- I52M (p.Ile52Met), TOPMed rs1362739690, Likely benign
- I52V (p.Ile52Val), rs200996010, ClinGen CA195738465, ClinVar RCV002650136, ClinVar RCV004747107, REVEL 0.26, CADD 20.70, Uncertain significance, not provided
- I52I (p.Ile52Ile), rs1362739690, gnomAD 9-84670904-C-T, CADD 14.10
- V53M (p.Val53Met), rs778391314, ClinGen CA5105414, NCI-TCGA Cosmic COSV5289, cosmic curated COSV52890, REVEL 0.07, CADD 18.70, Uncertain significance, not provided
- V53L (p.Val53Leu), gnomAD 9-84670905-G-T, REVEL 0.12, CADD 16.90
- V53V (p.Val53Val), rs750066853, gnomAD 9-84670907-G-A, CADD 13.30
- A54T (p.Ala54Thr), NCI-TCGA TCGA novel, TOPMed rs2058659147, REVEL 0.53, CADD 23.70, Variant assessed as somatic; moderate impact.
- A54S (p.Ala54Ser), gnomAD 9-84670908-G-T, REVEL 0.38, CADD 20.30
- A54V (p.Ala54Val), gnomAD 9-84670909-C-T, REVEL 0.71, CADD 24.00
- A54A (p.Ala54Ala), gnomAD 9-84670910-A-G, CADD 8.24
- P56L (p.Pro56Leu), NCI-TCGA Cosmic COSV5287, cosmic curated COSV52871, Ensembl rs2058659300, REVEL 0.81, CADD 25.10, Variant assessed as somatic; moderate impact.
- P56R (p.Pro56Arg), Ensembl rs2058659300, REVEL 0.85, CADD 26.70
- P56T (p.Pro56Thr), Ensembl rs2131268375
- P56Q (p.Pro56Gln), gnomAD 9-84670915-C-A, REVEL 0.84, CADD 26.90
- P56P (p.Pro56Pro), gnomAD 9-84670916-G-A, CADD 7.90
- R57I (p.Arg57Ile), rs758729728, ClinGen CA5105416, ClinVar RCV001819324, ClinVar RCV001869683, REVEL 0.62, CADD 22.80, Uncertain significance, not provided; not specified
- R57S (p.Arg57Ser), gnomAD 9-84670919-A-T, REVEL 0.65, CADD 18.90
- L58* (p.Leu58Ter), rs747571706, ClinGen CA374004889, ClinVar RCV003564760, AlphaMissense 0.38, MetaLR 0.91, Pathogenic
- L58S (p.Leu58Ser), cosmic curated COSV10437, ExAC rs747571706, gnomAD rs747571706, REVEL 0.84, AlphaMissense 0.38, Uncertain significance, not provided
- L58L (p.Leu58Leu), rs138465789, gnomAD 9-84670920-T-C, CADD 10.90
- L58F (p.Leu58Phe), gnomAD 9-84670922-G-T, REVEL 0.70, CADD 26.80
- E59A (p.Glu59Ala), TOPMed rs2058659849
- E59K (p.Glu59Lys), cosmic curated COSV52877
- E59Q (p.Glu59Gln), NCI-TCGA Cosmic COSV5287, NCI-TCGA Cosmic COSV9945, cosmic curated COSV99452, Variant assessed as somatic; moderate impact.
- E59D (p.Glu59Asp), gnomAD 9-84670925-G-T, REVEL 0.37, CADD 13.30
- P60H (p.Pro60His), cosmic curated COSV99454, ExAC rs769089926, gnomAD rs769089926, REVEL 0.42, AlphaMissense 0.10
- P60L (p.Pro60Leu), rs769089926, ClinGen CA374004903, ClinVar RCV003547851, AlphaMissense 0.10, MetaLR 0.95, Uncertain significance, not provided
- P60S (p.Pro60Ser), gnomAD 9-84670926-C-T, REVEL 0.32, CADD 6.43
- P60P (p.Pro60Pro), rs1237888351, gnomAD 9-84670928-T-C, CADD 10.70
- N61S (p.Asn61Ser), gnomAD 9-84670930-A-G, REVEL 0.02, CADD 10.90
- S62G (p.Ser62Gly), rs915858967, ClinGen CA195738466, ClinVar RCV002808797, ClinVar RCV005059282, REVEL 0.18, AlphaMissense 0.22, Uncertain significance, not provided; Inborn genetic diseases
- S62R (p.Ser62Arg), rs915858967, ClinGen CA374004913, cosmic curated COSV52887, ClinVar RCV002048211, AlphaMissense 0.22, MetaLR 0.34, Uncertain significance, not provided
- S62I (p.Ser62Ile), gnomAD 9-84670933-G-T, REVEL 0.33, CADD 15.80
- S62S (p.Ser62Ser), rs948040979, gnomAD 9-84670934-T-C, CADD 12.00
- V63A (p.Val63Ala), Ensembl rs2058660683, REVEL 0.09, CADD 12.10
- V63I (p.Val63Ile), cosmic curated COSV52878, Ensembl rs2131268767
- D64A (p.Asp64Ala), rs781249905, ClinGen CA374004929, ClinVar RCV003824761, ClinVar RCV005377575, REVEL 0.25, CADD 24.80, Uncertain significance, not provided; Inborn genetic diseases
- D64E (p.Asp64Glu), 1000Genomes rs201875843, TOPMed rs201875843, REVEL 0.08, CADD 11.10
- D64G (p.Asp64Gly), ExAC rs781249905, TOPMed rs781249905, gnomAD rs781249905, REVEL 0.27, CADD 24.70, Uncertain significance
- D64N (p.Asp64Asn), cosmic curated COSV10941
- D64H (p.Asp64His), gnomAD 9-84670938-G-C, REVEL 0.26, CADD 27.30
- D64Y (p.Asp64Tyr), gnomAD 9-84670938-G-T, REVEL 0.39, CADD 27.90
- D64V (p.Asp64Val), gnomAD 9-84670939-A-T, REVEL 0.35, CADD 27.60
- P65H (p.Pro65His), NCI-TCGA Cosmic COSV5285, cosmic curated COSV52858, Variant assessed as somatic; moderate impact.
- P65T (p.Pro65Thr), Ensembl rs2058661256, Uncertain significance, NTRK2-related disorder
- P65S (p.Pro65Ser), gnomAD 9-84670941-C-T, REVEL 0.05, CADD 10.90
- P65L (p.Pro65Leu), rs1470117060, gnomAD 9-84670941-C-CT, CADD 26.20
- P65P (p.Pro65Pro), gnomAD 9-84670943-T-G, CADD 8.36
Public NTRK2 analysis runs
- NTRK2 analysis run — NTRK2 (2,449 variants) — completed 2026-08-18